Compare Genuine Parts Company (GPC) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Genuine Parts Company vs Medpace Holdings Inc — how do they compare? Genuine Parts Company trades at $135.1 (market cap $18.62B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Genuine Parts Company and Medpace Holdings Inc are close in size by market cap, and Genuine Parts Company pays a 3.15% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| GPC | MEDP | |
|---|---|---|
Market Cap | $18.62B | $16.90B |
Sector | Consumer Cyclical | Technology |
52-Week High | $149.26 | $620.59 |
52-Week Low | $92.47 | $393.42 |
Enterprise Value | $24.72B | $16.52B |
Dividend Yield | 3.15% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Genuine Parts Company
Genuine Parts sells automotive parts (about two thirds of net sales) and industrial components. The company sells vehicle parts to commercial and retail customers through roughly 9,700 stores worldwide, most of which are independently owned. Its industrial unit, primarily operating under the Motion Industries banner in the United States, supplies bearings, power transmission, industrial automation, hydraulic, and pneumatic components to maintenance, repair, and OEM clients.
Read more on GPC →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
